Xiaosong Huang

ORCID: 0000-0003-0627-1509
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • Nutrition, Genetics, and Disease
  • Global Cancer Incidence and Screening
  • Genetic Associations and Epidemiology
  • Cancer Genomics and Diagnostics
  • Molecular Biology Techniques and Applications
  • Cytokine Signaling Pathways and Interactions
  • Health Literacy and Information Accessibility
  • Cancer Risks and Factors
  • Cancer-related molecular mechanisms research
  • Health Systems, Economic Evaluations, Quality of Life
  • Glycosylation and Glycoproteins Research
  • Forensic and Genetic Research
  • RNA modifications and cancer
  • interferon and immune responses
  • Race, Genetics, and Society

University of California, Davis
2022-2024

Abstract Background: A substantial portion of the genetic predisposition for breast cancer is explained by multiple common variants relatively small effect. subset these variants, which have been identified mostly in individuals European and Asian ancestry, combined to construct a polygenic risk score (PRS) predict risk, but prediction accuracy existing PRSs Hispanic/Latinx (H/L) remain low. We assessed performance several PRS panels with without addition H/L specific among self-reported...

10.1158/1055-9965.epi-24-1247 article EN cc-by-nc-nd Cancer Epidemiology Biomarkers & Prevention 2024-12-03

Breast cancer is the most common in women United States (U.S.) and leading cause of related death among U.S. Hispanics/Latinas (H/Ls). H/Ls have lower rates screening longer time to follow up after an abnormal mammogram. We developed a comprehensive community health educator (promotores)-led education risk identification program for Spanish-speaking California increase mammography screening, genetic testing, understanding impact family history on risk. Due COVID-19, we adapted virtual...

10.1002/jgc4.1793 article EN cc-by Journal of Genetic Counseling 2023-09-25

Abstract Breast cancer subtype distribution differs between populations with dissimilar genetic ancestry backgrounds. Several breast risk single nucleotide polymorphisms (SNPs) were discovered in individuals of European and Asian origin. Hispanic/Latina women remain underrepresented studies public databases. The 6q25 locus contains multiple risk-associated SNPs. Some SNPs within this region have been associated the expression genes (eQTLs), such as Estrogen Receptor 1 gene (ESR1). Two...

10.1158/1538-7755.disp22-c082 article EN Cancer Epidemiology Biomarkers & Prevention 2023-01-01

Abstract Background: Breast cancer is the most common among women in US and leading cause of death who self-identify as Hispanics/Latinas (H/L). Approximately 5-10% breast can be attributed to inherited genetic mutations high penetrance genes such BRCA1 BRCA2. Studies have shown that counseling help their families make informed decisions about testing, which turn lead life-saving preventative strategies. H/L are less likely undergo testing than Non-Hispanic White women. To address this...

10.1158/1538-7755.disp22-c071 article EN Cancer Epidemiology Biomarkers & Prevention 2023-01-01

Abstract Genetic studies in women of Hispanic/Latina origin identified a single nucleotide polymorphism (SNP) the 6q25 region, rs140068132, that correlates with Indigenous American (IA) ancestry and is protective against BC. The underrepresentation Latin populations public databases has hindered study mechanisms by which this SNP confers effect. We aimed to identify IA germline variants associated BC risk test their association tumor gene expression region. performed case-control...

10.1158/1538-7445.am2023-5237 article EN Cancer Research 2023-04-04

Abstract Purpose: Breast cancer incidence and outcomes differ by US census racial/ethnic category. Since large-scale genetic studies of human disease are predominately focused on populations European ancestry, little is known about breast molecular biology in Hispanic/Latinos which can widen health disparities due to suboptimal translation discoveries into clinical practice or public policy. We aim describe relevant pathways subtype differentiation patients from Peru. Patients Methods:...

10.1158/1538-7445.am2023-5235 article EN Cancer Research 2023-04-04

Abstract Around 10% of genetic predisposition for breast cancer is explained by mutations in high/moderate penetrance genes. The remaining proportion multiple common variants relatively small effect. A subset these has been identified mostly Europeans and Asians; combined into polygenic risk scores (PRS) to predict risk. Our aim identify a improve prediction Hispanics/Latinas (H/Ls).Breast patients were recruited at the Instituto Nacional de Enfermedades Neoplásicas Peru, be part Peruvian...

10.1158/1538-7445.am2022-3683 article EN Cancer Research 2022-06-15
Coming Soon ...